Voloridge Investment Management
ESPR

Voloridge Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Voloridge Investment Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-170,838
Closed -$272K – 1415
2023
Q1 		$272K Sell
170,838
-508,692
-75% -$2.63M ﹤0.01% 1284
2022
Q4 		$4.23M Buy
+679,530
New +$4.86M 0.02% 704
2022
Q3 		– Sell
-137,744
Closed -$876K – 1451
2022
Q2 		$876K Sell
137,744
-400,112
-74% -$2.27M ﹤0.01% 1219
2022
Q1 		$2.5M Sell
537,856
-104,179
-16% -$447K 0.01% 875
2021
Q4 		$3.21M Buy
642,035
+385,274
+150% +$3.08M 0.02% 896
2021
Q3 		$3.09M Buy
256,761
+191,967
+296% +$2.79M 0.02% 879
2021
Q2 		$1.37M Buy
+64,794
New +$1.56M 0.01% 1141
2021
Q1 		– Sell
-49,643
Closed -$1.29M – 1473
2020
Q4 		$1.29M Buy
+49,643
New +$1.49M 0.01% 887
2020
Q1 		– Sell
-6,441
Closed -$384K – 1175
2019
Q4 		$384K Buy
+6,441
New +$290K 0.01% 870
2019
Q3 		– Sell
-5,571
Closed -$259K – 1111
2019
Q2 		$259K Buy
+5,571
New +$262K 0.01% 669
2018
Q1 		– Sell
-67,666
Closed -$4.46M – 535
2017
Q4 		$4.46M Sell
67,666
-23,814
-26% -$1.28M 0.1% 221
2017
Q3 		$4.58M Sell
91,480
-9,839
-10% -$474K 0.1% 194
2017
Q2 		$4.69M Buy
101,319
+43,884
+76% +$1.61M 0.12% 180
2017
Q1 		$2.03M Buy
+57,435
New +$1.32M 0.05% 315
2015
Q4 		– Sell
-214,162
Closed -$5.05M – 218
2015
Q3 		$5.05M Buy
+214,162
New +$13.4M 0.24% 110

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Voloridge Investment Management's ESPR Position: Q2 2023 in Review

Voloridge Investment Management sold out of Esperion Therapeutics (ESPR) in Q2 2023, closing a stake of 170,838 shares — an estimated $272K sold.

Voloridge Investment Management first reported a position in ESPR in Q3 2015 and held it in 15 quarters. The position peaked at $5.05M in Q3 2015. 124 funds tracked by Wall St. Rank hold ESPR as of Q2 2023.

  • Voloridge Investment Management reported no remaining Esperion Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 170,838 Esperion Therapeutics shares in Q2 2023, an estimated $272K.
  • Voloridge Investment Management first reported a position in Esperion Therapeutics in Q3 2015 and held it in 15 quarters.
  • Voloridge Investment Management's Esperion Therapeutics position peaked at $5.05M in Q3 2015.
  • 124 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.